Becton, Dickinson Aktie
| 227,58USD | 2,42USD | 1,07% |
WKN: 857675 / ISIN: US0758871091
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 72 000 | 75 000 | 77 000 | 73 000 | 74 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,24 | 0,27 | 0,25 | 0,27 | 0,27 |
Bilanz (in Mio. USD) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 8 969 | 8 838 | 8 141 | 8 676 | 10 468 |
| Summe Anlagevermögen | 45 043 | 45 028 | 44 793 | 44 104 | 46 818 |
| Summe Aktiva | 54 012 | 53 866 | 52 934 | 52 780 | 57 286 |
Bilanz (in Mio. USD) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 30 247 | 30 189 | 27 652 | 26 983 | 31 396 |
| Summe Eigenkapital | 23 765 | 23 677 | 25 282 | 25 797 | 25 890 |
| Summe Passiva | 54 012 | 53 866 | 52 934 | 52 780 | 57 286 |
Adresse
| 1 Becton Drive, 07417-1880 Franklin Lakes | |
| Telefon | +1 (201) 847-6800 |
| Internet | http://www.bd.com |
Management
|
Ami E. Simunovich
Chief Quality & Regulatory Officer, Executive VP |
|
Antoine Ezell
Chief Marketing Officer & EVP-North America |
|
Antoinette F. Segreto
Senior Vice President-Taxes |
|
Bertram L. Scott
Lead Independent Director |
|
Brooke Story
President-Integrated Diagnostic Solutions |
|
Carrie L. Byington
Independent Director |
|
Catherine M. Burzik
Independent Director |
|
Christopher Ian Montague Jones
Independent Director |
|
Christopher J. DelOrefice
Chief Financial Officer & Executive Vice President |
|
Claire M. Fraser-Liggett
Independent Director |
|
Claudia Curtis
Chief Ethics & Compliance Officer, Senior VP |
|
David Shan
Chief Quality Officer & Executive Vice President |
|
Denise Russell Fleming
Chief Information Officer & EVP-Technology |
|
Ebonee Lewis
Chief Employment Counsel |
|
Elizabeth McCombs
Chief Technology Officer & Executive VP |
|
Gary Michael DeFazio
Secretary, Senior VP & Associate General Counsel |
|
Gregory Rodetis
Treasurer, Senior VP & Head-Investor Relations |
|
Jeffrey William Henderson
Independent Director |
|
Joanne Waldstreicher
Independent Director |
|
Joseph M. Smith
Chief Scientific Officer & Senior Vice President |
|
Michael D. Garrison
Executive VP & President-Medical Segment |
|
Michael Feld
Executive Vice President & President-Life Sciences |
|
Michelle Quinn
Executive Vice President & General Counsel |
|
Pamela L. Spikner
Chief Accounting Officer, Senior VP & Controller |
|
Richard E. Byrd
Executive VP & President-Interventional Segment |
|
Rishi Grover
Chief Integrated Supply Chain Officer & EVP |
|
Robert Andrew Eckert
Independent Director |
|
Ronald P. Silverman
Chief Medical Officer & Executive Vice President |
|
Shana Carol Neal
Chief People Officer & Executive Vice President |
|
Stephen O. Richard
Chief Risk Officer & Senior Vice President |
|
Thomas E. Polen
Chairman, President & Chief Executive Officer |
|
Thomas J. Spoerel
Senior Vice President & Controller |
|
Timothy M. Ring
Independent Director |
|
Vishy Kanda
Chief Strategy Officer & Senior Vice President |
|
William M. Brown
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.